Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $690.43 million. The enterprise value is $728.04 million.
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 44.34 million shares outstanding. The number of shares has increased by 3.22% in one year.
| Current Share Class | 44.34M |
| Shares Outstanding | 44.34M |
| Shares Change (YoY) | +3.22% |
| Shares Change (QoQ) | +9.53% |
| Owned by Insiders (%) | 5.58% |
| Owned by Institutions (%) | 75.35% |
| Float | 38.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 52.18 |
| PS Ratio | 3.68 |
| Forward PS | 3.13 |
| PB Ratio | 6.62 |
| P/TBV Ratio | 7.02 |
| P/FCF Ratio | 481.47 |
| P/OCF Ratio | 152.25 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 211.21, with an EV/FCF ratio of 507.70.
| EV / Earnings | n/a |
| EV / Sales | 3.89 |
| EV / EBITDA | 211.21 |
| EV / EBIT | n/a |
| EV / FCF | 507.70 |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.68.
| Current Ratio | 3.24 |
| Quick Ratio | 1.88 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 8.57 |
| Debt / FCF | 49.57 |
| Interest Coverage | -0.40 |
Financial Efficiency
Return on equity (ROE) is -9.99% and return on invested capital (ROIC) is -1.20%.
| Return on Equity (ROE) | -9.99% |
| Return on Assets (ROA) | -1.03% |
| Return on Invested Capital (ROIC) | -1.20% |
| Return on Capital Employed (ROCE) | -1.90% |
| Revenue Per Employee | $414,465 |
| Profits Per Employee | -$22,044 |
| Employee Count | 452 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +122.29% in the last 52 weeks. The beta is 0.99, so Axogen's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +122.29% |
| 50-Day Moving Average | 17.76 |
| 200-Day Moving Average | 14.51 |
| Relative Strength Index (RSI) | 36.86 |
| Average Volume (20 Days) | 516,466 |
Short Selling Information
The latest short interest is 1.84 million, so 4.15% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short Previous Month | 1.51M |
| Short % of Shares Out | 4.15% |
| Short % of Float | 4.73% |
| Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, Axogen had revenue of $187.34 million and -$9.96 million in losses. Loss per share was -$0.23.
| Revenue | 187.34M |
| Gross Profit | 141.98M |
| Operating Income | -3.29M |
| Pretax Income | -16.54M |
| Net Income | -9.96M |
| EBITDA | 3.45M |
| EBIT | -3.29M |
| Loss Per Share | -$0.23 |
Full Income StatementBalance Sheet
The company has $33.48 million in cash and $71.09 million in debt, giving a net cash position of -$37.60 million or -$0.85 per share.
| Cash & Cash Equivalents | 33.48M |
| Total Debt | 71.09M |
| Net Cash | -37.60M |
| Net Cash Per Share | -$0.85 |
| Equity (Book Value) | 103.91M |
| Book Value Per Share | 2.35 |
| Working Capital | 68.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.54 million and capital expenditures -$3.10 million, giving a free cash flow of $1.43 million.
| Operating Cash Flow | 4.54M |
| Capital Expenditures | -3.10M |
| Free Cash Flow | 1.43M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 75.79%, with operating and profit margins of -1.75% and -5.32%.
| Gross Margin | 75.79% |
| Operating Margin | -1.75% |
| Pretax Margin | -5.32% |
| Profit Margin | -5.32% |
| EBITDA Margin | 1.84% |
| EBIT Margin | -1.75% |
| FCF Margin | 0.77% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.22% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.44% |
| FCF Yield | 0.21% |
Dividend DetailsAnalyst Forecast
The average price target for Axogen is $24.17, which is 55.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.17 |
| Price Target Difference | 55.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 16.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 1.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.97 |
| Piotroski F-Score | 4 |